Acquiring Company
Teleflex
Acquired Company
BIOTRONIK Neuro
Description
Teleflex has completed the acquisition of Biotronik's vascular intervention business for $895 million. This acquisition enables Teleflex to enhance its clinical trial program and expand its innovative product offerings in the cath lab. The deal aims to improve patient care and strengthen Teleflex's global presence. The completion was announced earlier than expected by Teleflex's CEO, Liam Kelly.
Quick answer
Teleflex is acquiring BIOTRONIK Neuro, announced July 2, 2025. Teleflex is based in Wayne, Pennsylvania, United States.
- How much did Teleflex pay for BIOTRONIK Neuro?
- The deal value was not disclosed.
- What does Teleflex do?
- Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives.
- Where are Teleflex and BIOTRONIK Neuro based?
- Teleflex is based in Wayne, Pennsylvania, United States. BIOTRONIK Neuro is based in Berlin, Berlin, Germany.
- Who are the decision-makers at Teleflex?
- Fundz holds 2 contacts at Teleflex. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- OSR Holdings to acquire Woori IO for healthcare innovation (July 24, 2025)
- Demetra acquires OrthoFundamentals for spine division (August 1, 2025)
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
- Concentra to acquire Elevation Oncology, shut it down (June 20, 2025)
- AbbVie to acquire Cerevel Therapeutics for $45 per share (May 28, 2025)
- Merit Medical acquires BioLife hemostasis products (May 21, 2025)
Who to call at Teleflex, and when
When Teleflex changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Teleflex raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Teleflex, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Teleflex. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Teleflex makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BIOTRONIK Neuro?
BIOTRONIK Neuro was acquired by Teleflex, based in Wayne. The deal was reported on July 2, 2025. Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company specializes in vascular intervention, surgical instruments, and anesthesia technologies. Teleflex is publicly traded (TFX) and operates in Biotechnology.
When did Teleflex acquire BIOTRONIK Neuro?
Teleflex's acquisition of BIOTRONIK Neuro was reported on July 2, 2025. Teleflex has completed the acquisition of Biotronik's vascular intervention business for $895 million. This acquisition enables Teleflex to enhance its clinical trial program and expand its innovative product offerings in the cath lab. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BIOTRONIK Neuro do?
BIOTRONIK Neuro is a division of BIOTRONIK, a leading global medical device company. The division specializes in innovative technologies for neuromodulation and spinal cord stimulation. It is privately held, operating in Manufacturing, and is based in Berlin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.